ブメタニド
| メーカー |
製品番号 |
製品説明 |
CAS番号 |
包装 |
価格 |
更新時間 |
購入 |
|
富士フイルム和光純薬株式会社(wako)
|
W01COBQA-7802 |
ブメタニド
Bumetanide |
28395-03-1 |
1g |
￥35000 |
2024-03-01 |
購入 |
|
富士フイルム和光純薬株式会社(wako)
|
W01COBQA-7802 |
ブメタニド
Bumetanide |
28395-03-1 |
5g |
￥140000 |
2024-03-01 |
購入 |
|
富士フイルム和光純薬株式会社(wako)
|
W01COBQA-7802 |
Bumetanide |
28395-03-1 |
25g |
￥560000 |
2024-03-01 |
購入 |
|
富士フイルム和光純薬株式会社(wako)
|
W01TRCB689550 |
Bumetanide |
28395-03-1 |
10g |
￥91900 |
2023-06-01 |
購入 |
|
富士フイルム和光純薬株式会社(wako)
|
W01COBQA-7802 |
Bumetanide |
28395-03-1 |
10g |
￥135000 |
2023-06-01 |
購入 |
ブメタニド 化学特性,用途語,生産方法
効能
利尿薬, Na-K-Cl共輸送体阻害薬
商品名
ルネトロン (第一三共); ルネトロン (第一三共)
化学的特性
Crystalline Solid
使用
Bumetanide is a diuretic.
定義
ChEBI: A member of the class of benzoic acids that is 4-phenoxybenzoic acid in which the hydrogens ortho to the phenoxy group are substituted by butylamino and sulfamoyl groups. Bumetanide is a diuretic, and is used for treatment of oedema associated
with congestive heart failure, hepatic and renal disease.
生物活性
Loop diuretic that inhibits the Na + /2Cl - /K + (NKCC) cotransporter. More potent than furosemide (5-(Aminosulfonyl)-4-chloro-2-([2-furanylmethyl]amino)benzoic acid ).
臨床応用
A diuretic structurally related to furosemide is bumetanide. This compound also functions as a high-ceiling diuretic in the ascending limb of the loop of Henle. It has a
duration of action of approximately 4 hours. The uses of this compound are similar to those described for furosemide. The dose of bumetanide is 0.5 to 2 mg/day given as
a single dose.
ブメタニド 上流と下流の製品情報
原材料
準備製品
ブメタニド 生産企業
Global( 305)Suppliers
28395-03-1(ブメタニド)キーワード:
- 28395-03-1
- segurex
- pf1593
- lunetoron
- fordiuran
- fontego
- burine
- Bumetanide (Ro 10-6338)
- Bemetanide
- 2-phenoxy-3-butylamino-5-carboxybenzenesulfonamide
- DONALD
- 3-ButylaMino-4-phenoxy-5-sulfaMylbenzoic acid
- 3-(AMinosulfonyl)-5-(butylaMino)-4-phenoxybenzoic acid, BuMex, Burinex
- Bumetanide (250 mg)
- Bumetanide,3-(Aminosulfonyl)-5-(butylamino)-4-phenoxybenzoic acid
- 3-n-Butylamino-4-phenoxy-5-sulfamoylbenzoic acid
- Bumetanide (FDA)
- pf159
- Bumetanide (125 mg)
- Benzoic acid, 3-(aminosulfonyl)-5-(butylamino)-4-phenoxy-
- Lixil
- Bufenox
- BumetanideUSP
- burinex
- BUMETANIDE
- 3-(AMINOSULFONYL)-5-(BUTYLAMINO)-4-PHENOXYBENZOIC ACID
- RO 10-6338
- 3-Butyuamino-4-phenoxy-5-sutfamoylbenzoicacid
- 3-(butylamino)-4-phenoxy-5-sulfamoyl-benzoicaci
- 3-(aminosulfonyl)-5-(butylamino)-4-phenoxy-benzoicaci
- BumetanideQ: What is
Bumetanide Q: What is the CAS Number of
Bumetanide Q: What is the storage condition of
Bumetanide Q: What are the applications of
Bumetanide
- ブメタナイド
- 3-ブチルアミノ-4-フェノキシ-5-スルファモイル安息香酸
- ブメックス
- リクシル
- 3-(アミノスルホニル)-5-(ブチルアミノ)-4-フェノキシ安息香酸
- ブフェノックス
- ブメタニド
- ルネトロン
- ホリジウラン
- ブリネックス
- 3-(ブチルアミノ)-4-フェノキシ-5-スルファモイル安息香酸
- ブメタニド (JP17)
- 利尿薬